1. Vosevi is a follow-up treatment for adults with chronic hepatitis C virus genotypes 1 through 6 who have mild or no cirrhosis.
2. Nerlynx is a treatment for early-stage breast cancer patients with a HER2 genetic mutation.
3. Lusdana Nexvue is a biosimilar version of Sanofi’s diabetes drug Lantus.
4. The Embrace Neonatal MRI System is an MRI device for infants in the neonatal intensive care unit.
More articles on supply chain:
5 steps to reduce blood costs at your hospital
Bloomberg: FedEx’s TNT ‘may never fully recover’ from Petya attack
5 must-reads for supply chain leaders this week
